In its white paper, Beyond Skin Deep: A Biomarker Framework for Mushroom-Supported Healthy Ageing, KÄÄPÄ Biotech examines how functional mushrooms, particularly Chaga (Inonotus obliquus), can be assessed through measurable biological mechanisms rather than broad wellness claims.
The paper explores the Hallmarks of Ageing and complementary Hallmarks of Health frameworks, which provide a scientific basis for understanding biological decline and resilience. It introduces a three-tier biomarker framework, distinguishing between visible outcomes, clinical surrogate markers and hallmark-level biomarkers that reveal underlying biological processes.
Chaga's bioactive profile is examined across four principal classes: polysaccharides, triterpenoids, polyphenols and melanins. The paper reviews available evidence linking these compounds to oxidative stress, cellular senescence, skin ageing, mitochondrial function, stem cell exhaustion, inflammation, glycation, gut microbiome health and metabolic ageing.
A particular focus is placed on a human proof-of-concept study involving KÄÄPÄ Biotech's NordRelease® organic Chaga extract. The study reported a 36% average increase in circulating endothelial stem cells compared with placebo following a single dose, alongside findings relating to mitochondrial resilience. However, the authors acknowledge that the trial involved only four healthy adults and requires further clinical investigation.
The white paper also highlights the importance of ingredient standardisation, explaining how differences in raw materials, cultivation and extraction methods can affect bioactive composition and the reliability of research findings.
Looking ahead, it identifies three priorities: larger human trials measuring multiple biomarkers, standardised extract characterisation to enable cross-study comparisons, and clearer differentiation between the mechanisms of individual bioactive classes.
Ultimately, KÄÄPÄ Biotech argues that credible healthy ageing positioning will depend on measurable mechanisms, well-characterised ingredients and robust human evidence, supported by an understanding of both biological decline and resilience.
To explore the scientific evidence, biomarker framework and research behind mushroom-supported healthy ageing, click here to read the full white paper.
